CanariaBio Inc.

5 clinical trials · Sponsor

Record	Firm	Date
Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer (NCT05605535)	CanariaBio Inc.	2023-02-07
A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer. (NCT05335993)	CanariaBio Inc.	2022-07-25
Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer (NCT04938583)	CanariaBio Inc.	2021-03-17
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery (NCT04498117)	CanariaBio Inc.	2020-08-25

Every clearance here is in the API, with alerts when new ones post.